Gary M. Ansel
Dr. Gary M. Ansel
Interventional Cardiologist/ Cardiac and Peripheral Vascular Intervention Specialist
Dr. Ansel is an active clinical consultant and proceduralist in all aspects of vascular medicine and cardiology. He has dedicated his career to facilitating a total vascular care program for patients.
|480Bio||Medical Advisor||Development of endoluminal bioabsorbable theraputic devices for peripheral and/or coronary vascular therapy.||Consulting Fees|
|Abbott||Scientific and Strategic Advisory Board Member||Development of advanced diagnostic and therapeutic medical systems for the treatment of vascular disease.||Consulting Fees|
|Best Doctors||Consultant||Medical diagnostic services.||Consulting Fees|
|Boston Scientific||Consultant||Consulting||Consulting Fees|
|Bryn Mawr Communications||Consultant||Consulting||Consulting Fees|
|Capture Vascular||Consultant||Bench studies, animal studies, design iterations, post-market registry for new catheter.||Consulting Fees/Equity|
|Cardinal Health||Consultant||Product and investment opportunities in the Cath Lab space.||Consulting Fees|
|Case Western||Consultant||Consulting||Consulting Fees|
|Cook Medical||Consultant||Consulting||Consulting Fees|
|Cordis||Preceptor||Drug device education and training||Consulting Fees|
|CSI||National Principal Investigator||Clinical trial of orbital atherectomy system in treating peripheral arterial disease.||Consulting Fees|
|Lake Region||Consultant||Development of minimally-invasive delivery systems and components in stimulation therapy, cardiovascular, peripheral, neurovascular, and vascular access.||Consulting Fees|
|Medtronic||Peripheral Advisory Board and Preceptor||Development of medical devices for treatment of peripheral vascular disease.||Consulting Fees|
|Novate||Consultant||Development of bioabsorbable filters for the prevention of pulmonary embolism.||Consulting Fees/Equity|
|Quality Management Consulting Group, Ltd.||Consultant||Consulting Peer Review Services||Consulting Fees|
|ReFlow||Consultant||Development of medical devices such as catheters to access discrete regions of the peripheral vasculature.||Consulting Fees/Equity|
|SurModics||SAB Member||Medical device coatings||Consulting Fees|
|Upstream||Consultant||Percutaneous transluminal catheters for retrograde angioplasty||Consulting Fees|
|Vadiswire||Advisory Board Member||Development of guidewires to access challenging peripheral vascular anatomy.||Equity|
|Vascular Dynamics||Data Safety and Monitoring Board Chair||Development of implants for the treatment of hypertension.||Consulting Fees|
|Vatrix||Scientific Advisory Board Member||Development of balloon devices for the treatment of aneurysmal disease.||Equity|
|VEINS||Associate Director||Provide comprehensive education to cardiology field for treatment of venous disease||Consulting Fees|
|VERVE||Symposium participant||Provide comprehensive education to Australian cardiology field for treatment of venous disease||Consulting Fees|
|Veryan Medical Limited||Consultant||Consulting re Vascular Stents||Consulting Fees/Equity|
|VIVA||Board of Directors Member||Not-For-Profit educational organization dedicated to advancing the field of vascular medicine and intervention through education and research.||Consulting Fees|
Two-Year Analysis of the Japanese Cohort From the Zilver PTX Randomized Controlled Trial Supports the Validity of Multinational Clinical Trials. Ohki T, Yokoi H, Kichikawa K, Kimura T, Snyder SA, Ragheb AO, O'Leary EE, Jaff MR, Ansel GM, Dake MD. J Endovasc Ther. 2014 Oct;21(5):644-53. doi: 10.1583/14-4753.1. PMID: 25290792 [PubMed - in process]
Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. Geraghty PJ, Mewissen MW, Jaff MR, Ansel GM; VIBRANT Investigators. J Vasc Surg. 2013 Aug;58(2):386-95.e4. doi: 10.1016/j.jvs.2013.01.050. Epub 2013 May 13. PMID: 23676191 [PubMed - indexed for MEDLINE]
US Patent 7220269 B1: Thrombectomy catheter system with occluder and method of using same.
Dr. Ansel is an internationally renowned interventional expert, both in peripheral vascular and cardiovascular procedures. He serves as an invited faculty member at many of the largest cardiovascular conferences and medical meetings all over the world.
Dr. Ansel has been appointed Associate Medical Director of the OhioHealth Research and Innovation Institute in Columbus, Ohio and is a member of the OhioHealth Research Industry Council. He serves as a primary investigator for numerous national and international research trials helping to develop improved patient care to those suffering with peripheral and cardiovascular disease. Dr. Ansel hosts several industry sponsored training courses attended by national and international physicians.
Currently, he serves as System Medical Chief, Vascular Program - OhioHealth, and Assistant Clinical Professor of Medicine in the Department of Internal Medicine at the University Of Toledo Medical Center, Toledo, Ohio.
Dr. Ansel is a founding board member of the Vascular InterVentional Advances Conference (VIVA) which is a non-profit organization dedicated to the education and research of vascular disease.
Dr. Ansel received his medical degree from The Ohio State University College of Medicine where he also completed a postgraduate research fellowship in cardiology. He completed his residency and internship at the Medical University of Ohio in Toledo, Ohio and received his post-fellowship training in peripheral vascular intervention at the Ochsner Clinic in New Orleans.
Dr. Ansel is affiliated with OhioHealth Heart and Vascular Physicians in Columbus, Ohio. He is a former member of the Peripheral Vascular Committee for the American College of Cardiology and continues to serve as a member of several professional societies. He has contributed to journals such as The New England Journal of Medicine, Circulation, Journal of Endovascular Therapy, and The American Journal of Cardiology and has authored many medical book chapters.